Axis-Shield PLC operates in the Analytical instruments sector. Axis-Shield PLC is an Anglo-Norwegian company, focused on the development and manufacture of in vitro diagnostic tests for use in clinical laboratories and at the point of care. It is organized into three business divisions: Point of Care Division, Laboratory Division and Direct Distribution Division. The Point of Care Division comprises activities associated with tests performed at the point of consultation with healthcare professionals. The Laboratory Division concentrates on in vitro diagnostics tests for use in the clinical laboratory. The Direct Distribution Division is an independent arms-length operation that sells both its in-house products and third party products. On January 21, 2010 and March 12, 2010, it acquired the Chinese and United States distribution rights for its Point-of-Care products and certain related business. On December 15, 2010, it acquired the global, clinical chemistry homocysteine business of Catch Incorporated. In our complete report available for purchase the company is compared to: Optos PLC, AES Chemunex SA and Corin Group Plc.